NPI: 1255420436 · BURBANK, CA 91506 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,836 | $1.75M |
| 2019 | 19,265 | $820K |
| 2020 | 15,028 | $610K |
| 2021 | 21,520 | $990K |
| 2022 | 15,090 | $812K |
| 2023 | 20,188 | $1.08M |
| 2024 | 15,150 | $802K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,210 | 7,521 | $1.00M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,628 | 4,422 | $907K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,520 | 2,428 | $772K |
| S4993 | Contraceptive pills for birth control | 6,268 | 6,250 | $643K |
| J3490 | Unclassified drugs | 18,572 | 15,803 | $581K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9,453 | 8,268 | $570K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,672 | 5,450 | $522K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,713 | 1,674 | $323K |
| 87806 | 10,553 | 8,096 | $260K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 623 | 622 | $244K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 228 | 228 | $214K |
| 99201 | 1,139 | 978 | $138K | |
| 58300 | 919 | 462 | $90K | |
| A4267 | Contraceptive supply, condom, male, each | 11,391 | 11,256 | $90K |
| 11981 | 233 | 232 | $56K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 4,002 | 4,002 | $51K |
| 81025 | 14,189 | 13,757 | $46K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 477 | 477 | $42K |
| S5000 | Prescription drug, generic | 6,117 | 5,761 | $42K |
| J7300 | Intrauterine copper contraceptive (paragard) | 51 | 51 | $42K |
| 83986 | 11,385 | 9,367 | $30K | |
| 99401 | 1,516 | 1,507 | $29K | |
| 99000 | 7,731 | 7,673 | $27K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 89 | 89 | $27K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 6,893 | 6,664 | $25K |
| 11976 | 322 | 162 | $18K | |
| 86703 | 1,255 | 1,007 | $14K | |
| 58301 | 427 | 220 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 450 | 434 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 451 | 434 | $7K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 12 | 12 | $6K |
| 81002 | 2,470 | 2,404 | $5K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,171 | 1,149 | $4K |
| 82120 | 971 | 935 | $3K | |
| 87210 | 949 | 925 | $3K | |
| 99402 | 83 | 83 | $3K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | 12 | 12 | $2K |
| 86592 | 625 | 624 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 221 | 201 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 53 | 53 | $688.44 |
| 36416 | 33 | 33 | $0.00 |